Latest news






Interviews



Newsletters
From the partners

21/10/21 – How the EU Pharmaceutical Strategy could help prevent the next pandemic


14/04/21 – BioVersys receives €20 million in EU financing to support development of new antibiotics

30/03/21 – Astellas and TB Alliance Enter into a New Collaborative Research Agreement to Identify Lead Compounds for the Treatment of Tuberculosis

AMR ACCELERATOR NEWSLETTER – November 2023
ERA4TB Newsletter – October 2023
AMR ACCELERATOR NEWSLETTER – May 2023
UNITE4TB Newsletter – May 2023
ERA4TB Newsletter – April 2023
UNITE4TB Newsletter – December 2022